Cargando…
COVID-19 variants’ cross-reactivity on the paper microfluidic particle counting immunoassay
SARS-CoV-2 has mutated many times since the onset of the COVID-19 pandemic, and the omicron is currently the most dominant variant. Determining the specific strain of the virus is beneficial in providing proper care and containment of the disease. We have previously reported a novel method of counti...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491260/ https://www.ncbi.nlm.nih.gov/pubmed/36131142 http://dx.doi.org/10.1007/s00216-022-04333-8 |